Oracle Co. (NYSE:ORCL) Shares Sold by Bath Savings Trust Co

Bath Savings Trust Co lessened its stake in shares of Oracle Co. (NYSE:ORCLFree Report) by 2.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,918 shares of the enterprise software provider’s stock after selling 150 shares during the quarter. Bath Savings Trust Co’s holdings in Oracle were worth $1,179,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the company. Bank of New Hampshire boosted its holdings in shares of Oracle by 0.4% during the third quarter. Bank of New Hampshire now owns 21,835 shares of the enterprise software provider’s stock worth $3,721,000 after purchasing an additional 93 shares during the last quarter. Salvus Wealth Management LLC acquired a new position in shares of Oracle during the 3rd quarter valued at about $582,000. Fragasso Financial Advisors Inc boosted its position in shares of Oracle by 2.6% in the third quarter. Fragasso Financial Advisors Inc now owns 34,941 shares of the enterprise software provider’s stock worth $5,954,000 after acquiring an additional 874 shares during the last quarter. Fulton Bank N.A. increased its position in Oracle by 93.8% during the third quarter. Fulton Bank N.A. now owns 41,001 shares of the enterprise software provider’s stock worth $6,987,000 after purchasing an additional 19,850 shares during the last quarter. Finally, Platte River Wealth Advisors LLC raised its stake in Oracle by 11.7% during the third quarter. Platte River Wealth Advisors LLC now owns 2,875 shares of the enterprise software provider’s stock worth $490,000 after purchasing an additional 300 shares during the period. Institutional investors and hedge funds own 42.44% of the company’s stock.

Oracle Stock Down 0.5 %

ORCL stock opened at $169.94 on Tuesday. The stock has a market cap of $470.91 billion, a PE ratio of 45.81, a price-to-earnings-growth ratio of 3.09 and a beta of 1.01. The firm’s 50-day simple moving average is $147.84 and its 200 day simple moving average is $135.24. Oracle Co. has a fifty-two week low of $99.26 and a fifty-two week high of $173.99. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 6.68.

Oracle (NYSE:ORCLGet Free Report) last issued its quarterly earnings data on Monday, September 9th. The enterprise software provider reported $1.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.33 by $0.06. Oracle had a return on equity of 171.38% and a net margin of 20.40%. The business had revenue of $13.31 billion during the quarter, compared to analyst estimates of $13.23 billion. During the same period in the prior year, the company posted $0.95 EPS. The business’s revenue for the quarter was up 6.9% compared to the same quarter last year. As a group, sell-side analysts predict that Oracle Co. will post 5 EPS for the current year.

Oracle Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 24th. Shareholders of record on Thursday, October 10th will be paid a dividend of $0.40 per share. The ex-dividend date is Thursday, October 10th. This represents a $1.60 annualized dividend and a yield of 0.94%. Oracle’s payout ratio is 43.13%.

Insider Buying and Selling

In related news, insider Edward Screven sold 426,861 shares of the firm’s stock in a transaction dated Wednesday, July 10th. The stock was sold at an average price of $141.91, for a total transaction of $60,575,844.51. Following the completion of the transaction, the insider now owns 2,626,764 shares of the company’s stock, valued at $372,764,079.24. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Oracle news, insider Edward Screven sold 426,861 shares of the business’s stock in a transaction dated Wednesday, July 10th. The stock was sold at an average price of $141.91, for a total transaction of $60,575,844.51. Following the sale, the insider now owns 2,626,764 shares in the company, valued at approximately $372,764,079.24. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Leon E. Panetta sold 15,000 shares of Oracle stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $137.89, for a total transaction of $2,068,350.00. Following the completion of the transaction, the director now directly owns 58,090 shares in the company, valued at approximately $8,010,030.10. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,573,181 shares of company stock valued at $225,338,245 over the last quarter. Corporate insiders own 42.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ORCL has been the subject of several research reports. UBS Group boosted their price objective on shares of Oracle from $160.00 to $175.00 and gave the company a “buy” rating in a research note on Tuesday, September 10th. Sanford C. Bernstein upped their price target on Oracle from $201.00 to $202.00 and gave the stock an “outperform” rating in a research note on Monday, September 30th. StockNews.com raised shares of Oracle from a “hold” rating to a “buy” rating in a research note on Tuesday, September 10th. Stifel Nicolaus increased their price objective on shares of Oracle from $135.00 to $155.00 and gave the company a “hold” rating in a research report on Tuesday, September 10th. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Oracle in a research report on Tuesday, September 10th. Ten research analysts have rated the stock with a hold rating and twenty have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $167.42.

Read Our Latest Analysis on ORCL

Oracle Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Recommended Stories

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.